Integer Hldgs Corp Stock Price, News & Analysis

Integer Holdings (NYSE: ITGR) announced a leadership transition as Joseph Dziedzic plans to retire as President and CEO effective October 24, 2025. Payman Khales, current Chief Operating Officer, will succeed as President and CEO and join the Board of Directors.

Under Dziedzic's eight-year tenure, Integer focused on high-growth markets, enhanced investment in differentiated technologies, and implemented the Integer Production System. Khales, who joined in 2018 as President of Cardio & Vascular business, has demonstrated strong leadership by doubling the division's sales in seven years and achieving above-market growth. As COO, he currently oversees both Cardio & Vascular and Cardiac Rhythm Management & Neuromodulation business units.

To ensure a smooth transition, Dziedzic will serve as an advisor through March 31, 2026.

Integer Holdings (NYSE:ITGR) reported strong Q1 2025 results with sales increasing 7% to $437 million and organic growth of 6%. The company's GAAP operating income rose 28% to $50 million, while adjusted operating income grew 14% to $71 million.

Key highlights include Cardio & Vascular sales growth of 17% and Cardiac Rhythm Management & Neuromodulation sales increase of 2%. The company completed a $1.0 billion convertible notes offering, expecting $13 million reduction in interest expense for 2025.

Integer updated its 2025 outlook, projecting sales growth of 8-10% ($1.846-1.880 billion) and raising adjusted net income growth outlook to 19-26%. The company also announced CEO Joseph Dziedzic's planned retirement, with COO Payman Khales set to assume the position in October 2025.

Integer Holdings (NYSE: ITGR), a contract development and manufacturing organization, has issued a statement regarding the impact of recent trade policy developments and tariffs on its business. The company expects the announced tariffs to have an immaterial impact on its 2025 results.

CEO Joseph Dziedzic stated that the company estimates a $1 to $5 million impact on full-year adjusted operating income, which accounts for currently applicable tariffs and additional tariffs announced on April 2 following a 90-day pause. This estimate includes both implemented and planned mitigation actions. Integer will release its Q1 2025 financial results on April 24, 2025.

Integer Holdings (NYSE: ITGR) has announced that holders of its 2.125% Convertible Senior Notes due 2028 can now convert their notes from April 1, 2025, to June 30, 2025. The conversion opportunity arose because the company's stock price exceeded 130% of the conversion price for at least 20 trading days within a 30-day trading period ending March 31, 2025.

The notes are convertible into cash up to the principal amount, and the remainder can be settled in cash, shares, or a combination thereof at Integer's discretion. The conversion rate is set at 11.4681 shares of common stock per $1,000 principal amount, equivalent to a conversion price of approximately $87.20 per share.

Integer Holdings (NYSE: ITGR) has announced its upcoming first quarter 2025 earnings release and conference call schedule. The company will release its financial and operational results on Thursday, April 24, 2025 at 7 a.m. Central Time / 8 a.m. Eastern Time.

Management will host a webcast at 8 a.m. CT / 9 a.m. ET to discuss the quarterly results. The conference call will be accessible via domestic dial-in (800-715-9871) and international dial-in (646-307-1963) using Conference ID 3120125. An audio replay will be available for seven days following the call.

Integer Holdings (NYSE: ITGR) has successfully closed a $1.0 billion convertible senior notes offering due 2030, with a 1.875% interest rate. The offering was upsized from the initial $750 million due to strong investor demand, with initial purchasers exercising their option for an additional $125 million.

The company expects net proceeds of $976.1 million after expenses, which will be used to pay for capped call transactions, exchange existing convertible notes, and repay revolving credit facility and term A loan borrowings. The transaction is projected to generate $12 million in interest expense savings for 2025.

The notes' conversion structure includes cash payment for the principal amount and protection against dilution through capped call transactions, setting an effective conversion price of $189.44, representing a 60% premium over the March 13, 2025 closing stock price of $118.40.

Integer Holdings (NYSE: ITGR) has announced the pricing of $875.0 million convertible senior notes due 2030, upsized from the previously announced $750.0 million. The notes will carry a 1.875% interest rate and mature on March 15, 2030.

The company expects net proceeds of approximately $853.9 million (or $976.1 million if the initial purchasers exercise their additional notes option). Integer will use about $62.1 million for capped call transactions and $384.4 million to exchange approximately $383.7 million of existing 2.125% convertible notes due 2028.

The notes will be convertible at an initial rate of 6.6243 shares per $1,000 principal amount, equivalent to a conversion price of $150.96 per share, representing a 27.5% premium over the March 13, 2025 closing price of $118.40.

Integer Holdings (NYSE: ITGR) has announced plans to offer $750.0 million in convertible senior notes due 2030, with an additional option for purchasers to acquire up to $125.0 million. The company will implement capped call transactions to reduce potential stock dilution and plans to use the proceeds to:

• Pay for capped call transactions
• Exchange a portion of existing 2.125% convertible notes due 2028
• Repay borrowings under the company's credit agreement
• Fund general corporate purposes

The notes will mature on March 15, 2030, with conversion options available under specific conditions before December 15, 2029, and freely thereafter. Integer may redeem the notes after March 20, 2028, if the stock price maintains 140% of the conversion price for at least 20 trading days within a 30-day period.

Integer Holdings (NYSE:ITGR) reported strong Q4 and full-year 2024 results, with Q4 sales increasing 11% to $449 million and full-year sales up 10% to $1.717 billion. The company's Q4 GAAP income from continuing operations rose 23% to $33 million, while adjusted EBITDA grew 11% to $95 million.

For the full year 2024, GAAP income from continuing operations increased 36% to $121 million, and adjusted EBITDA rose 19% to $361 million. The company generated $205 million in operating cash flow. Integer completed the acquisition of Precision Coating for $152 million and signed an agreement to acquire VSi Parylene for $28 million.

Looking ahead to 2025, Integer expects 8-10% sales growth with expanding margins. The Cardio & Vascular segment showed strong performance with 15% growth in Q4 2024, while Cardiac Rhythm Management & Neuromodulation sales increased 11%.